Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma
- 31 March 2004
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 58 (3) , 768-772
- https://doi.org/10.1016/j.ijrobp.2003.07.002
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer1International Journal of Radiation Oncology*Biology*Physics, 2001
- Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic unitsBritish Journal of Surgery, 1997
- Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves SurvivalAnnals of Surgery, 1997
- Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomyInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidineInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 PatientsAnnals of Surgery, 1995
- Current Management of Pancreatic CarcinomaAnnals of Surgery, 1995
- Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracilInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Resection Margins in Carcinoma of the Head of the PancreasAnnals of Surgery, 1993
- Adjuvant therapy of resected adenocarcinoma of the pancreasInternational Journal of Radiation Oncology*Biology*Physics, 1991